Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 05 2026 titled Receipt of final approval by our Subsi...more...
Press release regarding receipt of final approval by our Subsidiary Caplin Steriles Limited from USFDA for Calcium Gluconate Injection USPmore...
As of March 2026 70.57% is owned by Indian Promoters and 29.43% by Public. Institutional holds 8.29% (Insurance Companies 0.01%) and Non-Institutiona...more...
Caplin Point Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026more...
Caplin Point Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tr...more...
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 13 2026 titled Receipt of final approval by our Sub...more...
Press release regarding receipt of final approval by our subsidiary Caplin Steriles Limited from USFDA for the Potassium Phosphates Injection USPmore...
Caplin Point Laboratories Limited has informed the Exchange regarding Cessation of Dr. C K Gariyali as Non- Executive Independent Director of the com...more...
Cessation of Dr. C K Gariyali as an Independent Director of the Company with effect from March 3 2026.more...
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 28 2026 titled Receipt of final approval by our ...more...
Press Release regarding receipt of final approval by our Subsidiary Caplin Steriles Limited from USFDA for the Desmopressin Acetate Injection USPmore...
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 24 2026 titled Receipt of final approval by our ...more...
Press release regarding receipt of final approval by our Subsidiary Caplin Steriles Limited from the USFDA for the Sodium Phosphates Injection USPmore...
Caplin Point Laboratories Limited has informed the Exchange about Transcriptmore...
Transcript of the Earnings Call - Q3 - FY 2025-26more...
Caplin Point Laboratories Limited has informed the Exchange about Link of Recordingmore...
Results - Analyst/Investor Meet - Earnings Call - Q3(2025-2026) - Audio Recordingmore...
Caplin Point Laboratories Limited has informed the Exchange about Investor Presentationmore...
The company reported standalone net profit of Rs 87.28 crore for the quarter ended December 31 2025 as compared to Rs 74.71 crore in the sam...more...
BOARD MEETINGS Company Name : Aakaar Medical Tech Date : 15-05-2026